Vitamin D therapy and cardiac structure and function in patients with chronic kidney disease: the PRIMO randomized controlled trial.
about
Adaptive designs undertaken in clinical research: a review of registered clinical trialsLeft Ventricular Hypertrophy in Chronic Kidney Disease Patients: From Pathophysiology to Treatment.Effect of Vitamin D Receptor Activators on Glomerular Filtration Rate: A Meta-Analysis and Systematic ReviewAn Investigation of the Shortcomings of the CONSORT 2010 Statement for the Reporting of Group Sequential Randomised Controlled Trials: A Methodological Systematic ReviewInterplay of vitamin D, erythropoiesis, and the renin-angiotensin systemHeart failure in patients with chronic kidney disease: a systematic integrative reviewVitamin D, calcium, and atherosclerotic risk: evidence from serum levels and supplementation studiesPulmonary hypertension in renal disease: epidemiology, potential mechanisms and implicationsAre there ways to attenuate arterial calcification and improve cardiovascular outcomes in chronic kidney disease?The effects of short-term vitamin D supplementation on glucose metabolism in dialysis patients: a systematic review and meta-analysisCardiovascular Risk Factors and Chronic Kidney Disease-FGF23: A Key Molecule in the Cardiovascular DiseaseCalcium and phosphate impact cardiovascular risk.Optimal management of bone mineral disorders in chronic kidney disease and end stage renal diseaseEvolution of Cardiovascular Disease During the Transition to End-Stage Renal Disease.Low dietary vitamin D in mid-life predicts total mortality in men with hypertension: the Honolulu heart program.High-dose cholecalciferol reduces parathyroid hormone in patients with early chronic kidney disease: a pilot, randomized, double-blind, placebo-controlled trial.Impact of new vitamin D data on future studies and treatment.Effect of Vitamin D Supplementation on Blood Pressure: A Systematic Review and Meta-analysis Incorporating Individual Patient Data.Higher fibroblast growth factor-23 concentrations associate with left ventricular systolic dysfunction in dialysis patientsCardiovascular disease in CKD in 2012: moving forward, slowly but surely.Associations of FGF-23 and sKlotho with cardiovascular outcomes among patients with CKD stages 2-4The use of fibroblast growth factor 23 testing in patients with kidney disease.Ergocalciferol and microcirculatory function in chronic kidney disease and concomitant vitamin d deficiency: an exploratory, double blind, randomised controlled trial.Fibroblast growth factor-23 and incident atrial fibrillation: the Multi-Ethnic Study of Atherosclerosis (MESA) and the Cardiovascular Health Study (CHS).The VITAH trial VITamin D supplementation and cardiac Autonomic tone in Hemodialysis: a blinded, randomized controlled trialThe influence of vitamin D analogs on calcification modulators, N-terminal pro-B-type natriuretic peptide and inflammatory markers in hemodialysis patients: a randomized crossover study.Incidence of Vitamin D Insufficiency in Coastal South-Eastern US Patient Population With Cardiovascular DiseaseOptimal management of hyperphosphatemia in end-stage renal disease: an Indian perspective.A randomized control trial to assess the impact of vitamin D supplementation compared to placebo on vascular stiffness in chronic kidney disease patients.Vitamin D treatment and mortality in chronic kidney disease: a systematic review and meta-analysis.Vitamin D: Metabolism, Molecular Mechanism of Action, and Pleiotropic Effects.Active vitamin D and accelerated progression of aortic stiffness in hemodialysis patients: a longitudinal observational study.Impact of vitamin D on chronic kidney diseases in non-dialysis patients: a meta-analysis of randomized controlled trials.Low vitamin D concentration is not associated with increased mortality and morbidity after cardiac surgeryActive vitamin D treatment for reduction of residual proteinuria: a systematic review.Prevention of chronic kidney disease and subsequent effect on mortality: a systematic review and meta-analysis.Effect of oral vitamin D analogs on mortality and cardiovascular outcomes among adults with chronic kidney disease: a meta-analysis.Vitamin D receptor agonist VS-105 improves cardiac function in the presence of enalapril in 5/6 nephrectomized rats.Serum parathyroid hormone and 25-hydroxyvitamin D concentrations and risk of incident heart failure: the Multi-Ethnic Study of Atherosclerosis.Vitamin D depletion aggravates hypertension and target-organ damage
P2860
Q26753245-A0259333-A6D6-4102-9058-B0E324DE7149Q26773120-A531F82C-BE74-4811-A22D-928DA7EA76C1Q26774371-691215EB-2AEE-45DE-8DEB-BE303CADCF96Q26777085-04B426BE-179F-407B-8F36-FCE6E142C25EQ26822500-68273327-82D7-4DB9-857D-BD8A296B88D1Q26824149-6C02D6D3-76E4-4290-8024-D9B70D1D141FQ26991851-5E65CB2D-A12F-4BDE-BE7A-44F456C68E43Q26996772-97E916D9-DC83-434D-BA62-FD2A570721BDQ27002431-8366814F-D917-49C3-A46D-9E0DB3DB6000Q27021893-E6FD2768-CEA7-4C1B-9A05-040EC68080E9Q27024043-0065B68A-3590-4B1E-8E21-B4F21C341984Q27687570-BE697A00-AE07-4287-96F7-5D19E252B893Q28072340-2709ED26-C599-4091-B489-5EFAAA9A72BCQ30234797-30F19EB1-F21B-4F2F-84CB-F220FB413A77Q30359753-64A44DE4-73F5-494B-B643-B4EA9B964BB5Q30524139-0649AB30-0469-4FA5-98FB-4404150816E1Q30624696-562D5391-00C5-44E1-B0FF-4E2F15F898FEQ30910917-CDD76C39-BA0D-43AB-AE4D-1891EB2CAA70Q33600110-3F921EC6-5CE5-4D75-9D76-3BE230A4A3B7Q33682243-A4C21D4C-69E3-4B0F-8562-A25C8A8A1053Q33715785-4A92E9A6-DF21-4ED3-B3A9-2A8AEB42CC30Q33835743-86B1D05F-8195-48EB-8DDA-BF012660C573Q33875012-697DE31F-C0E7-4416-911C-FE561F9D15EAQ33940724-7D766E5A-895D-4D80-B70B-91C05657986AQ34033076-04211464-FAE6-4153-B48D-38D63F1CBFEBQ34059805-F159CD90-BF4A-4571-88A4-01FBA14B94A1Q34213057-91C3ADB3-EC61-4715-AEED-301B6C470E83Q34415635-9CF85921-70D0-4032-A96E-FC137B5587DDQ34505057-F2AE8137-A853-4A8A-AB3C-C2E8EB2AA42CQ34610602-5DF26914-49B6-40B0-94EC-70CB4FFFA581Q34621641-2029A171-BBE7-4C18-BE6C-B011654983ACQ34683694-AB93FB4D-CEF4-4684-A26E-B92D8B214828Q34692107-7D2F866E-F489-4A68-A6AE-667E7608F7CBQ34749343-7433B1D1-C880-4A4E-80C0-00A9572C573CQ34912750-129DF62E-FCB9-423A-9B62-C165723D0D75Q34979484-597274E9-2913-469F-8A73-4997894981EAQ35026470-DA0C93A8-E2B3-4432-BA54-1DA38CBB1309Q35086461-8AA96EBA-360E-42DF-A1A8-28E67D14061EQ35115028-2E1EB4EA-D50E-4C8B-858F-FE0D114E211BQ35135697-2FC9836F-6D1E-4DD3-9092-A1758993FE80
P2860
Vitamin D therapy and cardiac structure and function in patients with chronic kidney disease: the PRIMO randomized controlled trial.
description
2012 nî lūn-bûn
@nan
2012 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Vitamin D therapy and cardiac ...... O randomized controlled trial.
@ast
Vitamin D therapy and cardiac ...... O randomized controlled trial.
@en
Vitamin D therapy and cardiac ...... O randomized controlled trial.
@nl
type
label
Vitamin D therapy and cardiac ...... O randomized controlled trial.
@ast
Vitamin D therapy and cardiac ...... O randomized controlled trial.
@en
Vitamin D therapy and cardiac ...... O randomized controlled trial.
@nl
prefLabel
Vitamin D therapy and cardiac ...... O randomized controlled trial.
@ast
Vitamin D therapy and cardiac ...... O randomized controlled trial.
@en
Vitamin D therapy and cardiac ...... O randomized controlled trial.
@nl
P2093
P50
P921
P356
P1476
Vitamin D therapy and cardiac ...... MO randomized controlled trial
@en
P2093
Ajay Pachika
B Taylor Thompson
Bhupinder Singh
Christoph Wanner
Daniel Zehnder
David Packham
Dennis Andress
Evan Appelbaum
Hector Tamez
P304
P356
10.1001/JAMA.2012.120
P407
P577
2012-02-01T00:00:00Z